News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News EuroPCR 2019 Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis L.A. McKeown June 07, 2019
News Conference News EuroPCR 2019 Allegra TAVR System Feasible for Treating Degenerated Surgical Valves Michael O'Riordan May 29, 2019
News Conference News EuroPCR 2019 Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE Michael O'Riordan May 24, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019
News Conference News EuroPCR 2019 BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels L.A. McKeown May 22, 2019
News Conference News EuroPCR 2019 Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION L.A. McKeown May 22, 2019
Presentation EuroPCR 2019 Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session Presenter: Bernardo Cortese May 21, 2019
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News EuroPCR 2018 DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes Caitlin E. Cox May 25, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
Presentation EuroPCR 2018 Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2) Presenter: Panagiotis Xaplanteris May 23, 2018
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
Presentation EuroPCR 2018 ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease Presenter: Rasha Al-Lamee May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018